Chair: Steven Hyman, Provost, Harvard University

Mitchell Adams, Executive Director, Massachusetts Technology Collaborative

Christopher Anderson, President, Massachusetts High Technology Council (MHTC)

Robert Anderson, Division Counsel, Abbott Laboratories

Aram Chobanian, Dean Emeritus and former President, Boston University

Charles Cooney, Director, Deshpande Center for Technological Innovation, MIT

Franklin Douglas, Executive Director, Center for Biomedical Innovation, MIT

Wendy Everett, President, New England Healthcare Institute (NEHI)

Thomas Finneran, President, Massachusetts Biotechnology Council (MBC)

David Fleming, Group Senior Vice President, Genzyme

Gary Gottlieb, President, Brigham and Women's Hospital

C. Jeffrey Grogan, Partner, Monitor Group

Paul Grogan, President, The Boston Foundation

Paul Guzzi, President, Greater Boston Chamber of Commerce

Robert Healy, City Manager, City of Cambridge

Ranch Kimball, Secretary, Executive Office of Economic Development and Technology,   Commonwealth of Massachusetts

Patrick Larkin, Director, John Adams Innovation Institute

Reid Leonard, Senior Director of Licensing & External Research, Merck Research Laboratories

Lisa Lopez, Executive Vice President & General Counsel, Haemonetics Corporation

Mark Maloney, Director, Boston Redevelopment Authority

Richard Packer, President and CEO, ZOLL Medical Corporation

Joyce Plotkin, President, Massachusetts Technology Leadership Council

Kevin O’Sullivan, President and CEO, Massachusetts Biomedical Initiatives

Peter Slavin, Chief Executive Officer, Massachusetts General Hospital

Thomas Sommer, President, Massachusetts Medical Device Industry Council (MassMEDIC)

Marilyn Swartz-Lloyd, President and CEO, Medical Academic and Scientific Community Organization, Inc. (MASCO)

Jack Wilson, President, University of Massachusetts

Return to front page of Convergence.